Overcoming Barriers to CAR T Referral in R/R MM

Spain is one of the countries that has made the strongest commitment to the development of CAR-T therapies, treatments that are revolutionizing the approach to several types of serious cancer.In fact, our public health system is one of the first in the world to offer these therapies, whose cost would otherwise make them virtually inaccessible to those who need them: their price can reach around 320,000 euros per patient.These treatments are rece…

Overcoming Barriers to CAR T Referral in R/R MM

Experts discuss the challenges and barriers to early referral for chimeric antigen receptor (CAR) T-cell therapy, including logistical, financial, and patient-related factors that may impact timely access to treatment.